PFBT
NRIX icon

Parkside Financial Bank & Trust’s Nurix Therapeutics NRIX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$884 Sell
57
-35
-38% -$580 ﹤0.01% 2395
2025
Q4 		$1.75K Buy
92
+90
+4,500% +$1.29K ﹤0.01% 2152
2025
Q3 		$19 Sell
2
-98
-98% -$1.02K ﹤0.01% 2696
2025
Q2 		$1.14K Buy
+100
New +$1.08K ﹤0.01% 2220

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Parkside Financial Bank & Trust's NRIX Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its Nurix Therapeutics (NRIX) stake by 38% in Q1 2026, selling an estimated $580 and leaving 57 shares worth $884. The position accounts for ﹤0.01% of the portfolio, ranked #2395.

Parkside Financial Bank & Trust first reported a position in NRIX in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.75K in Q4 2025. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • Parkside Financial Bank & Trust held 57 shares of Nurix Therapeutics worth $884 as of Q1 2026.
  • Parkside Financial Bank & Trust sold 35 Nurix Therapeutics shares in Q1 2026, an estimated $580.
  • Nurix Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2395 holding.
  • Parkside Financial Bank & Trust first reported a position in Nurix Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Parkside Financial Bank & Trust's Nurix Therapeutics position peaked at $1.75K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.